Related Experiment Video
Updated: May 10, 2026
04:53
A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
Ibn Sina and the clinical trial
Mohammad M Sajadi1, Davood Mansouri, Mohamad-Reza M Sajadi
1University of Maryland School of Medicine and Veteran Affairs Medical Center, Baltimore, Maryland, USA. msajadi@ihv.umaryland.edu
Annals of Internal Medicine
|May 6, 2009
Summary
Over 1000 years ago, Ibn Sina outlined 7 conditions for drug testing, laying the groundwork for modern clinical trials. This article explores his early work on experimental medicine and pharmacology.
Area of Science:
- * History of Medicine
- * Pharmacology
- * Clinical Trial Development
Background:
- * Exploration of Ibn Sina's (Avicenna) life and historical context.
- * Introduction to his seminal treatise on evaluating medicinal properties through experimentation.
Discussion:
- * Analysis of Ibn Sina's 7 conditions for drug recognition.
- * Comparison of his early methods with contemporary clinical trial principles.
- * Examination of the logical and empirical approaches in his work.
Key Insights:
- * Ibn Sina's treatise represents the earliest known precursor to formal clinical trial methodologies.
- * His work highlights a sophisticated understanding of experimental drug evaluation over a millennium ago.
- * Demonstrates the enduring relevance of historical medical insights.
Outlook:
- * Further research into historical medical texts for foundational scientific principles.
- * Integrating historical perspectives into modern pharmacology and clinical trial design.
- * Appreciating the long evolution of evidence-based medicine.
Related Concept Videos
02:07Blind Procedures
Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to control for experimenter bias. Experimenter bias refers to the possibility that a researcher’s expectations might skew the results of the study. Remember, conducting an experiment requires a lot of planning, and the people involved in the research project have a vested interest in supporting their hypotheses. If the observers knew which child was...
01:16Clinical Trials
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
01:11Blinding
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
01:27Nursing Clinical Information System
Nursing Clinical Information System (NCIS)
A Nursing Clinical Information System (NCIS) is a specialized type of healthcare information system tailored to meet the unique needs of nursing practice. It incorporates the principles of nursing informatics to streamline information management and improve the quality of care delivery.
Critical attributes of NCIS include:
A Nursing Clinical Information System (NCIS) is a specialized type of healthcare information system tailored to meet the unique needs of nursing practice. It incorporates the principles of nursing informatics to streamline information management and improve the quality of care delivery.
Critical attributes of NCIS include:
01:11Clinical Trials: Overview
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...